| MCO |
Report |
Adjusted diluted EPS |
BEAT |
pred ~$4.31 vs. cons $4.23 |
MEDIUM |
| MCO |
Report |
Total revenue |
BEAT |
pred ~$2.12B vs. cons $2.09B |
MEDIUM |
| MCO |
Report |
Moody's Investors Service (MIS) revenue |
BEAT |
pred ~$1.17B vs. cons $1.15B |
MEDIUM |
| MCO |
Guide |
FY2026 adjusted diluted EPS |
UNCHANGED |
guide ~$16.40-$17.00 vs. cons $16.71 (FY2026) |
HIGH |
| MCO |
Guide |
FY2026 MIS revenue growth |
UNCHANGED |
guide ~8% vs. cons 8% (FY2026) |
MEDIUM |
| MCO |
Guide |
FY2026 MA ARR growth |
UNCHANGED |
guide ~8% vs. cons 8% (FY2026) |
MEDIUM |
| MCO |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.8% |
— |
MEDIUM |
| MCO |
Return |
5-day cumulative residual |
+0.8% (FADE) |
A ~$4.31 EPS print versus $4.23 and ~$2.12B revenue versus $2.09B should initially reward solid issuance conversion, but an unchanged ~$16.40-$17.00 FY EPS framework versus $16.71 consensus limits out-period estimate revisions; the initial ~+1.8% residual is likely to fade toward ~+0.8% by day five. |
MEDIUM |